Grifols TDMonitor assays

Grifols has launched a therapeutic drug monitoring testing service as part of its Texas-based clinical diagnostics laboratory menu. Its TDMonitor assays measure levels of infliximab, Humira (adalimumab), and Entyvio (vedolizumab) and the antidrug antibodies, and support therapeutic decisions by clinicians.